$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21 2021 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 9.42 | 23,900 | 225,138 | 23,900 | |
| May 21 2021 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 9.42 | 23,900 | 225,138 | 23,900 | |
| May 21 2021 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 9.42 | 23,900 | 225,138 | 23,900 | |
| May 11 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Buy | P | 8.60 | 23,250 | 199,992 | 131,802 | 108.6 K to 131.8 K (+21.42 %) |
| May 10 2021 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Buy | P | 7.82 | 4,000 | 31,280 | 4,000 | 0 to 4 K |
| May 04 2021 | KPTI | Karyopharm Therape ... | Paulson Richard A. | President and CEO | Option Exercise | A | 9.44 | 559,800 | 5,284,512 | 559,800 | |
| May 04 2021 | KPTI | Karyopharm Therape ... | Paulson Richard A. | President and CEO | Grant | A | 0.00 | 373,200 | 0 | 373,200 | 0 to 373.2 K |
| Mar 23 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
| Mar 23 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Grant | A | 0.00 | 22,013 | 0 | 107,691 | 85.7 K to 107.7 K (+25.69 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Grant | A | 0.00 | 22,013 | 0 | 51,755 | 29.7 K to 51.8 K (+74.01 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Grant | A | 0.00 | 22,013 | 0 | 45,401 | 23.4 K to 45.4 K (+94.12 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Grant | A | 0.00 | 22,013 | 0 | 104,439 | 82.4 K to 104.4 K (+26.71 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 14.56 | 43,177 | 628,657 | 43,177 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Grant | A | 0.00 | 15,849 | 0 | 23,995 | 8.1 K to 24 K (+194.56 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Sell | S | 14.83 | 1,186 | 17,590 | 51,791 | 53 K to 51.8 K (-2.24 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Sell | S | 14.83 | 2,887 | 42,818 | 46,126 | 49 K to 46.1 K (-5.89 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
| Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Buy | M | 0.00 | 5,650 | 0 | 6,189 | 539 to 6.2 K (+1,048.24 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, Chief Dev. Off ... | Buy | M | 0.00 | 5,650 | 0 | 41,384 | 35.7 K to 41.4 K (+15.81 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 8,150 | 0 | 24,450 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Buy | M | 0.00 | 8,150 | 0 | 8,150 | 0 to 8.2 K |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.00 | 14,300 | 0 | 569,422 | 555.1 K to 569.4 K (+2.58 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.00 | 14,300 | 0 | 770,789 | 756.5 K to 770.8 K (+1.89 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 14,300 | 0 | 42,900 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 770,789 | 756.5 K to 770.8 K (+1.89 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 14,300 | 0 | 569,422 | 555.1 K to 569.4 K (+2.58 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Buy | M | 0.00 | 5,650 | 0 | 49,875 | 44.2 K to 49.9 K (+12.78 %) |
| Dec 22 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 5.43 | 5,000 | 27,150 | 0 | |
| Dec 22 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 18.00 | 5,000 | 90,000 | 0 | 5 K to 0 (-100.00 %) |
| Dec 22 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 5.43 | 5,000 | 27,150 | 5,000 | 0 to 5 K |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 5.43 | 20,000 | 108,600 | 5,000 | |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 16.14 | 5,000 | 80,704 | 0 | 5 K to 0 (-100.00 %) |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 16.04 | 5,000 | 80,223 | 5,000 | 10 K to 5 K (-50.00 %) |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 16.05 | 5,000 | 80,227 | 10,000 | 15 K to 10 K (-33.33 %) |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 16.05 | 5,000 | 80,231 | 15,000 | 20 K to 15 K (-25.00 %) |
| Dec 08 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 5.43 | 20,000 | 108,600 | 20,000 | 0 to 20 K |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 58,937 | 612,355 | 16,842 | |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.45 | 78,124 | 816,396 | 46,876 | |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.35 | 58,937 | 1,022,557 | 4,523 | 63.5 K to 4.5 K (-92.87 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 58,937 | 612,355 | 63,460 | 4.5 K to 63.5 K (+1,303.05 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.66 | 78,124 | 1,379,670 | 4,523 | 82.6 K to 4.5 K (-94.53 %) |
| Dec 03 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.45 | 78,124 | 816,396 | 82,647 | 4.5 K to 82.6 K (+1,727.26 %) |
| Nov 30 2020 | KPTI | Karyopharm Therape ... | Schor Chen | Director | Option Exercise | A | 14.75 | 32,800 | 483,800 | 32,800 | |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | M | 0.00 | 765 | 0 | 2,295 | |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Sell | S | 15.58 | 226 | 3,521 | 539 | 765 to 539 (-29.54 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Buy | M | 0.00 | 765 | 0 | 765 | 0 to 765 |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 2,413 | 0 | 7,237 | |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Sell | S | 19.46 | 589 | 11,462 | 43,229 | 43.8 K to 43.2 K (-1.34 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Buy | M | 0.00 | 2,413 | 0 | 43,172 | 40.8 K to 43.2 K (+5.92 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 14.92 | 772 | 11,518 | 4,523 | 5.3 K to 4.5 K (-14.58 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 721 | 7,491 | 75,779 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 9.21 | 38,550 | 355,046 | 64,250 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.20 | 721 | 12,401 | 4,649 | 5.4 K to 4.6 K (-13.43 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 721 | 7,491 | 5,370 | 4.6 K to 5.4 K (+15.51 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.85 | 38,550 | 649,568 | 4,649 | 43.2 K to 4.6 K (-89.24 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 9.21 | 38,550 | 355,046 | 43,199 | 4.6 K to 43.2 K (+829.21 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 6,076 | 201 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,424 | 47 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.89 | 7,500 | 111,683 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 6,076 | 201 | 763,989 | 757.9 K to 764 K (+0.80 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,424 | 47 | 757,913 | 756.5 K to 757.9 K (+0.19 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 721 | 7,491 | 75,779 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 9.21 | 38,550 | 355,046 | 64,250 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.20 | 721 | 12,401 | 4,649 | 5.4 K to 4.6 K (-13.43 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 721 | 7,491 | 5,370 | 4.6 K to 5.4 K (+15.51 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.85 | 38,550 | 649,568 | 4,649 | 43.2 K to 4.6 K (-89.24 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 9.21 | 38,550 | 355,046 | 43,199 | 4.6 K to 43.2 K (+829.21 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 6,076 | 201 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,424 | 47 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.89 | 7,500 | 111,683 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 6,076 | 201 | 763,989 | 757.9 K to 764 K (+0.80 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,424 | 47 | 757,913 | 756.5 K to 757.9 K (+0.19 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 6,076 | 201 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 1,424 | 47 | 0 | |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 14.89 | 7,500 | 111,683 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 6,076 | 201 | 763,989 | 757.9 K to 764 K (+0.80 %) |
| Oct 14 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 1,424 | 47 | 757,913 | 756.5 K to 757.9 K (+0.19 %) |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 10,054 | 65,753 | 0 | |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 14.98 | 10,054 | 150,609 | 4,649 | 14.7 K to 4.6 K (-68.38 %) |
| Sep 10 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 10,054 | 65,753 | 14,703 | 4.6 K to 14.7 K (+216.26 %) |
| Aug 31 2020 | KPTI | Karyopharm Therape ... | Oliger Christy J. | Director | Option Exercise | A | 0.00 | 32,800 | 0 | 32,800 | |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1,477 | 49 | 6,076 | |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.00 | 1,477 | 22,155 | 756,489 | 758 K to 756.5 K (-0.19 %) |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1,477 | 49 | 757,966 | 756.5 K to 758 K (+0.20 %) |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 1,477 | 49 | 6,076 | |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 15.00 | 1,477 | 22,155 | 756,489 | 758 K to 756.5 K (-0.19 %) |
| Aug 18 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 1,477 | 49 | 757,966 | 756.5 K to 758 K (+0.20 %) |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 1,424 | |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.43 | 7,500 | 145,723 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 7,500 | 248 | 1,424 | |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.43 | 7,500 | 145,723 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jul 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 377,803 | |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 333,561 | |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.53 | 7,500 | 146,487 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.71 | 300 | 5,912 | 555,122 | 555.4 K to 555.1 K (-0.05 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.98 | 7,200 | 136,627 | 555,422 | 562.6 K to 555.4 K (-1.28 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 333,561 | |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 377,803 | |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.71 | 300 | 5,912 | 555,122 | 555.4 K to 555.1 K (-0.05 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.98 | 7,200 | 136,627 | 555,422 | 562.6 K to 555.4 K (-1.28 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.53 | 7,500 | 146,487 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jul 13 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 8,924 | |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 7,500 | 248 | 8,924 | |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jun 24 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 357 | 12 | 0 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,143 | 236 | 16,424 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.20 | 357 | 5,783 | 756,489 | 756.8 K to 756.5 K (-0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 357 | 12 | 756,846 | 756.5 K to 756.8 K (+0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.38 | 7,143 | 116,996 | 756,489 | 763.6 K to 756.5 K (-0.94 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,143 | 236 | 763,632 | 756.5 K to 763.6 K (+0.94 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 357 | 12 | 0 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 7,143 | 236 | 16,424 | |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.20 | 357 | 5,783 | 756,489 | 756.8 K to 756.5 K (-0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 357 | 12 | 756,846 | 756.5 K to 756.8 K (+0.05 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.38 | 7,143 | 116,996 | 756,489 | 763.6 K to 756.5 K (-0.94 %) |
| Jun 17 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 7,143 | 236 | 763,632 | 756.5 K to 763.6 K (+0.94 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 385,303 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 7,500 | 35,640 | 341,061 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.50 | 7,500 | 138,746 | 756,489 | 764 K to 756.5 K (-0.98 %) |